TITLE

Molecular mechanisms in lung cancer

PUB. DATE
December 2004
SOURCE
Thorax;Dec2004 Supplement, Vol. 59, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents some papers related to molecular mechanisms in lung cancer. There is increasing evidence that immune surveillance plays a critical role in the prevention and prognosis in a variety of carcinomas. The role played by the innate immune system in determining the clinical outcome from non small cell lung cancer is unclear. Macrophages and mast cells were identified using mAb to CD68 and tryptase respectively. Areas of tumor islets and stroma were identified and the area calculated using image analysis.
ACCESSION #
17564511

 

Related Articles

  • The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Ibaraki, Toshihiko; Muramatsu, Michiko; Takai, Shinji; Jin, Denan; Maruyama, Hiroshi; Orino, Tatsuhiko; Katsumata, Takahiro; Miyazaki, Mizuo // European Journal of Cardio-Thoracic Surgery;Oct2005, Vol. 28 Issue 4, p617 

    Abstract: Objective: There are two types of human mast cells, tryptase-positive mast cells (MCT) and tryptase- and chymase-positive mast cells (MCTC). Although MCT have been reported to be related to the generation of angiogenesis, little is known about the involvement of MCTC in tumor...

  • Erratum to: RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China. Qiang Lin; Junfeng Geng; Kelong Ma; Jian Yu; Jinfeng Sun; Zhenya Shen; Guoliang Bao; Yinming Chen; Hongyu Zhang; Yinghua He; Xiaoying Luo; Xu Feng; Jingde Zhu // Journal of Cancer Research & Clinical Oncology;Jan2010, Vol. 136 Issue 1, p171 

    A correction to the article "RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China," which appeared in a previous issue, is presented.

  • Erlotinib.  // Reactions Weekly;2/5/2011, Issue 1337, p18 

    The article describes several cases of women who developed cosmetic hair alterations while receiving treatment with erlotinib for non-small cell lung cancer.

  • Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. Ohri, Chandra M.; Shikotra, Aarti; Green, Ruth H.; Waller, David A.; Bradding, Peter // BMC Cancer;2010, Vol. 10, p172 

    Background: We have previously demonstrated that tumour islet infiltration by macrophages is associated with extended survival (ES) in NSCLC. We therefore hypothesised that patients with improved survival would have high tumour islet expression of chemokine receptors known to be associated with...

  • International Symposium "Mast Cells and Cellular Interactions" Berlin, Kaiserin-Friedrich-Stiftung, September 15-16, 1995. Henz, B. M.; Grabbe, J.; Kolde, G.; Krüger-Krasagakes, S.; Paus, R.; Zuberbier, T. // Journal of Investigative Dermatology;Nov95, Vol. 105 Issue 5, p715 

    This article provides information about an International Symposium on "Mast Cells and Cellular Interactions", which was held at Berlin, Kaiserin-Friedrich-Stiftung, during September 15-16, 1995. Mast cell precursors emerge from the bone marrow, and home to tissues where they complete their...

  • Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas. Schmid, Katharina; Angerstein, Nina; Geleff, Silvana; Gschwendtner, Andreas // Modern Pathology;Mar2006, Vol. 19 Issue 3, p453 

    The purpose of this study was to discriminate the main subsets of lung carcinomas of the WHO classification of 2004 by nuclear chromatin texture feature analysis. Our collective comprised 56 typical and 19 atypical carcinoids, 37 small-cell carcinomas, 15 large-cell neuroendocrine carcinomas, 42...

  • In this issue.  // International Immunology;Jul2012, Vol. 24 Issue 7, pNP 

    No abstract available.

  • Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer. Xuan Hong; Baohong Cui; Meng Wang; Zhaoyang Yang; Li Wang; Qingyong Xu // Tohoku Journal of Experimental Medicine;Aug2015, Vol. 236 Issue 4, p297 

    Small cell lung cancer (SCLC) is an aggressive disease characterized by rapid growth and metastases. It has been recognized that the inflammation of the microenvironment plays a critical role in the development of malignancies. However, little is known about the role of multiple inflammatory and...

  • Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer. Boldrini, Laura; Faviana, Pinuccia; Pistolesi, Francesca; Gisfredi, Silvia; Quirico, Dagmar Di; Lucchi, Marco; Mussi, Alfredo; Angeletti, Carlo Alberto; Baldinotti, Fulvia; Fogli, Antonella; Simi, Paolo; Basolo, Fulvio; Fontanini, Gabriella // Oncogene;10/4/2001, Vol. 20 Issue 45, p6632 

    The Fas (APO-1/CD95) system regulates a number of physiological and pathological processes of cell death. The ligand for Fas induces apoptosis by interacting with a transmembrane cell surface Fas receptor. The key role of the Fas system has been studied mostly in the immune system, but Fas...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics